Medplus Health Services Subsidiary Faces One-Day Drug License Suspension in Delhi
Medplus Health Services Limited reported that Optival Health Solutions Private Limited, a subsidiary of the company, received a suspension order for a Drug License pertaining to a store located in the state of Delhi.The action was issued by the Assistant Director, Drugs Control Administration, F-17, Karkardooma, Delhi. The suspension order was received on May 10, 2026.
The violation cited falls under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The specific action taken was the suspension of the Drug License for one day, affecting the store situated at Gopal Nagar, New Delhi.
The details of this regulatory matter are summarized below:
| Authority Name | Nature of Action | Date of Order | Violation Details | Financial Impact |
|---|---|---|---|---|
| Assistant Director, Drugs Control Administration, F-17, Karkardooma, Delhi | Suspension of Drug License for one day of store situated at Gopal Nagar, New Delhi. | 10.05.2026 | Under Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 | Potential Revenue Loss of Rs 0.30 lacs. |
MEDPLUS Stock Price Movement
Medplus Health Services Limited shares edged higher today, settling at ₹875.75 after gaining 0.61%. The stock saw a substantial trading day, supported by a total traded volume of 62,065 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.